CD22 and neoplasm: We explored the differential expression of the SIGLEC family in tumor and normal tissue in GEPIA and found that the content of CD22, SIGLEC7, and SIGLEC9 in the tumor was higher than that in normal tissue (Supplementary Figure 3B).